Summary
- Current Price
- As of today, TNGX price is $19.26, down -3.02% on
- Current Price All-Time High
- TNGX price is currently -11.73% below its historical high of $21.82 set on
- Market Cap
- TNGX current market cap is $3B, up +1390.28% over the past 365 days
- PE Ratio
- TNGX PE ratio is unknown
- Revenue
- TNGX current annual revenue is $62.38M, up +48.29% year-over-year
- Next Earnings
- The next earnings release for TNGX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Tango Therapeutics, Inc. |
| Ticker | NASDAQ: TNGX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | tangotx.com |
| Employees | 155 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $19.26 | |
| Price, 1D Change | -3.02% | |
| $3B | ||
| - | ||
| - | ||
| 1.47 | ||
| $62M | ||
| Revenue, 1Y Change | +48.29% | |
| -$0.87 | ||
| EPS, 1Y Change | +26.69% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | BCTG | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.87 | ||
| EPS Estimate | N/A | -$1.32 |
| EPS Est. Change | N/A | -50.80% |
| $62.38M | ||
| Revenue Estimate | N/A | $6.66M |
| Revenue Est. Change | N/A | -89.32% |
| Current Price | $19.26 | |
| Price Target | - | $19.00 |
| Price Tgt. Change | - | -1.35% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.21 | -$1.19 | +1.03% | |
| -$0.90 | -$0.87 | +2.58% | |
| -$1.32 | N/A | -50.80% | |
| -$1.53 | N/A | -75.22% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $45.99M | $42.07M | -8.53% | |
| $62.89M | $62.38M | -0.81% | |
| $6.66M | N/A | -89.32% | |
| $3.49M | N/A | -94.41% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $19.26 | |
| $9.29 | ||
| SMA 200 vs Price | -51.76% | |
| $14.27 | ||
| SMA 50 vs Price | -25.93% | |
| 1.47 | ||
| $1.20 | ||
| 66.25 | ||
| 59.88% | ||
| 112.07% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $62.38M | ||
| -$0.87 | ||
| $60.10M | ||
| 96.34% | ||
| -$111.29M | ||
| -178.39% | ||
| -$101.59M | ||
| -162.85% | ||
| -$109.01M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.10 | ||
| 16.32 | ||
| 16.32 | ||
| - | ||
| - | ||
| 22.55 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 41.58 | ||
| 7.49 | ||
| -20.95 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $346.18M | ||
| $343.57M | ||
| $410.01M | ||
| $353.76M | ||
| $63.83M | ||
| $21.68M | ||
| $33.57M | ||
| $2.74M | ||
| $1.18M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $163.98M | ||
| $171.39M | ||
| $2.28M | ||
| $0.00 | ||
| $2.28M | ||
| $0.00 | ||
| $4,000.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$138.89M | ||
| -$40.87M | ||
| $222.50M | ||
| $1.05M | ||
| -$139.93M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Mizuho | → | |
| Stifel | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Mizuho | ||
| Guggenheim | → | |
| Piper Sandler | → | |
| Stifel | ||
| Wolfe Research |
Analyst sentiment
Institutional ownership
Screeners with TNGX
FAQ
What is the ticker symbol for Tango Therapeutics, Inc.?
The ticker symbol for Tango Therapeutics, Inc. is NASDAQ:TNGX
Does Tango Therapeutics, Inc. pay dividends?
No, Tango Therapeutics, Inc. does not pay dividends
What sector is Tango Therapeutics, Inc. in?
Tango Therapeutics, Inc. is in the Healthcare sector
What industry is Tango Therapeutics, Inc. in?
Tango Therapeutics, Inc. is in the Biotechnology industry
What country is Tango Therapeutics, Inc. based in?
Tango Therapeutics, Inc. is headquartered in United States
When did Tango Therapeutics, Inc. go public?
Tango Therapeutics, Inc. initial public offering (IPO) was on September 3, 2020
Is Tango Therapeutics, Inc. in the S&P 500?
No, Tango Therapeutics, Inc. is not included in the S&P 500 index
Is Tango Therapeutics, Inc. in the NASDAQ 100?
No, Tango Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Tango Therapeutics, Inc. in the Dow Jones?
No, Tango Therapeutics, Inc. is not included in the Dow Jones index
When was Tango Therapeutics, Inc. last earnings report?
Tango Therapeutics, Inc.'s most recent earnings report was on March 5, 2026
When does Tango Therapeutics, Inc. report earnings?
The next expected earnings date for Tango Therapeutics, Inc. is May 11, 2026
Data Sources & References
- TNGX Official Website www.tangotx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1819133/000119312526092518/0001193125-26-092518-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1819133/000119312526092518/0001193125-26-092518-index.htm
- TNGX Profile on Yahoo Finance finance.yahoo.com/quote/TNGX
- TNGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tngx